“Sapheon will significantly enhance Covidien’s global peripheral vascular business by providing additional treatment options for physicians and their patients who suffer from [chronic venous insufficiency],” said Brian Verrier, president of peripheral vascular businesses of Covidien, in a news release.
Financial terms of the acquisition were not disclosed.
More articles on acquisitions:
Premier to acquire Aperek for $48.5M
5 recent device, biotech company acquisitions
What Cerner’s acquisition of Siemens Health Services will mean for the health IT market
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.